First Time Loading...

MedMira Inc
XTSX:MIR

Watchlist Manager
MedMira Inc Logo
MedMira Inc
XTSX:MIR
Watchlist
Price: 0.085 CAD 6.25%
Updated: Jun 10, 2024

Profitability Summary

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
MedMira Inc

Revenue
407.8k CAD
Cost of Revenue
-156.8k CAD
Gross Profit
251k CAD
Operating Expenses
-2.4m CAD
Operating Income
-2.2m CAD
Other Expenses
-737.9k CAD
Net Income
-2.9m CAD

Margins Comparison
MedMira Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CA
MedMira Inc
XTSX:MIR
59.6m CAD
62%
-536%
-717%
US
Shockwave Medical Inc
NASDAQ:SWAV
215.1B USD
87%
20%
21%
US
Abbott Laboratories
NYSE:ABT
187.9B USD
55%
16%
14%
US
Intuitive Surgical Inc
NASDAQ:ISRG
147.4B USD
66%
25%
27%
US
Stryker Corp
NYSE:SYK
131.9B USD
64%
21%
16%
US
Boston Scientific Corp
NYSE:BSX
113B USD
69%
17%
12%
IE
Medtronic PLC
NYSE:MDT
108.6B USD
66%
20%
11%
US
Becton Dickinson and Co
NYSE:BDX
69.1B USD
41%
11%
7%
DE
Siemens Healthineers AG
XETRA:SHL
61.3B EUR
38%
12%
8%
US
Edwards Lifesciences Corp
NYSE:EW
51.9B USD
77%
29%
23%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
362.5B CNY
65%
35%
34%
Country CA
Market Cap 59.6m CAD
Gross Margin
62%
Operating Margin
-536%
Net Margin
-717%
Country US
Market Cap 215.1B USD
Gross Margin
87%
Operating Margin
20%
Net Margin
21%
Country US
Market Cap 187.9B USD
Gross Margin
55%
Operating Margin
16%
Net Margin
14%
Country US
Market Cap 147.4B USD
Gross Margin
66%
Operating Margin
25%
Net Margin
27%
Country US
Market Cap 131.9B USD
Gross Margin
64%
Operating Margin
21%
Net Margin
16%
Country US
Market Cap 113B USD
Gross Margin
69%
Operating Margin
17%
Net Margin
12%
Country IE
Market Cap 108.6B USD
Gross Margin
66%
Operating Margin
20%
Net Margin
11%
Country US
Market Cap 69.1B USD
Gross Margin
41%
Operating Margin
11%
Net Margin
7%
Country DE
Market Cap 61.3B EUR
Gross Margin
38%
Operating Margin
12%
Net Margin
8%
Country US
Market Cap 51.9B USD
Gross Margin
77%
Operating Margin
29%
Net Margin
23%
Country CN
Market Cap 362.5B CNY
Gross Margin
65%
Operating Margin
35%
Net Margin
34%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
MedMira Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CA
MedMira Inc
XTSX:MIR
59.6m CAD
20%
-71%
18%
-339%
US
Shockwave Medical Inc
NASDAQ:SWAV
215.1B USD
25%
13%
15%
30%
US
Abbott Laboratories
NYSE:ABT
187.9B USD
15%
8%
11%
9%
US
Intuitive Surgical Inc
NASDAQ:ISRG
147.4B USD
16%
14%
14%
19%
US
Stryker Corp
NYSE:SYK
131.9B USD
19%
9%
14%
11%
US
Boston Scientific Corp
NYSE:BSX
113B USD
9%
5%
8%
6%
IE
Medtronic PLC
NYSE:MDT
108.6B USD
7%
4%
8%
6%
US
Becton Dickinson and Co
NYSE:BDX
69.1B USD
5%
2%
5%
4%
DE
Siemens Healthineers AG
XETRA:SHL
61.3B EUR
10%
4%
8%
5%
US
Edwards Lifesciences Corp
NYSE:EW
51.9B USD
22%
15%
22%
22%
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
362.5B CNY
36%
25%
34%
46%
Country CA
Market Cap 59.6m CAD
ROE
20%
ROA
-71%
ROCE
18%
ROIC
-339%
Country US
Market Cap 215.1B USD
ROE
25%
ROA
13%
ROCE
15%
ROIC
30%
Country US
Market Cap 187.9B USD
ROE
15%
ROA
8%
ROCE
11%
ROIC
9%
Country US
Market Cap 147.4B USD
ROE
16%
ROA
14%
ROCE
14%
ROIC
19%
Country US
Market Cap 131.9B USD
ROE
19%
ROA
9%
ROCE
14%
ROIC
11%
Country US
Market Cap 113B USD
ROE
9%
ROA
5%
ROCE
8%
ROIC
6%
Country IE
Market Cap 108.6B USD
ROE
7%
ROA
4%
ROCE
8%
ROIC
6%
Country US
Market Cap 69.1B USD
ROE
5%
ROA
2%
ROCE
5%
ROIC
4%
Country DE
Market Cap 61.3B EUR
ROE
10%
ROA
4%
ROCE
8%
ROIC
5%
Country US
Market Cap 51.9B USD
ROE
22%
ROA
15%
ROCE
22%
ROIC
22%
Country CN
Market Cap 362.5B CNY
ROE
36%
ROA
25%
ROCE
34%
ROIC
46%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More